Skip to main contentSkip to navigation
Sirius Investors

MRVFF Stock: Nuvo Pharmaceuticals Inc. Stock Price, Analysis & Insights

Get live MRVFF stock price $0.98, comprehensive Nuvo Pharmaceuticals Inc. stock analysis, charts, news, and expert forecast. Real-time MRVFF stock data and investment insights.

0.98
0.00%Today
MRVFFNuvo Pharmaceuticals Inc. • Other OTC • Healthcare
Market Cap
11.15M
Volume
100
52W High
1.25
52W Low
0.42

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Nuvo Pharmaceuticals Inc., which operates globally under the trade name Miravo Healthcare, specializes in delivering both prescription and over-the-counter medical products. The company's diverse portfolio addresses key therapeutic areas, including p...

Company Information

CEO
Jesse F. Ledger
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
101

Contact Information

Address
6733 Mississauga Road
Country
CA

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: 0.78) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Nuvo Pharmaceuticals Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Nuvo Pharmaceuticals Inc.
  • Investors should consider how Nuvo Pharmaceuticals Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

11.15M

P/E Ratio (TTM)

-19.59

Beta

0.78

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.